Litcius/Paper detail

Avelumab in combination with and/or following chemotherapy vs chemotherapy alone in patients with previously untreated epithelial ovarian cancer: Results from the phase 3 javelin ovarian 100 trial

JA Ledermann, N. Colombo, Amit M. Oza, Kenji Fujiwara, M. J. Birrer, Leslie M. Randall, Elena Poddubskaya, Giovanni Scambia, Yaroslav Shparyk, M.C. Lim, Snehalkumar M Bhoola, Joohyuk Sohn, Kan Yonemori, Ross Stewart, Xiu Juan Zhang, Fabian Zohren, Carlos Linn, Bradley J. Monk

2020Gynecologic Oncology58 citationsDOI

Topics & Concepts

JavelinMedicineAvelumabChemotherapyOvarian cancerEpithelial ovarian cancerOncologyInternal medicineCancerImmunotherapyNivolumabEngineeringThrowingMechanical engineeringOvarian cancer diagnosis and treatmentVirus-based gene therapy researchReproductive Biology and Fertility
Avelumab in combination with and/or following chemotherapy vs chemotherapy alone in patients with previously untreated epithelial ovarian cancer: Results from the phase 3 javelin ovarian 100 trial | Litcius